Mahmood Piraee (PhD, PharmD) Mahmood Piraee (PhD, PharmD) Published Jun 8, 2025 More people than ever are turning to GLP-1 receptor agonists medications originally designed for diabetes, now widely used for weight management
Fear conditioning : contextual (hippocampus) or tone-dependent (amygdala)
Studies in anesthetized rats demonstrated that intravenous Melanotan II (0.1-1 mg/kg) exerted dose-dependent inducer activity on erection by eliciting erectile events and shortening latency of the first erectile event
UK Market Analysis GLP-1 medications are driving expansion in the UK by addressing two major economic and public health challenges: soaring National Health Service (NHS) expenses and workforce inactivity due to obesity
Earlier this month, the FDA posted four warning letters to companies that have introduced unapproved GLP-1s, such as semaglutide, tirzepatide, and retatrutide, into interstate commerce